EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

FDA-Approved Antibacterials and Echinocandins

Othman Al Musaimi iD

Antibiotics · 07.02.2025 · 14 (2) · 166

DOI: 10.3390/antibiotics14020166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 07.02.2025. Verfasst von Othman Al Musaimi. Beteiligte Einrichtung: School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 1955, a total of 12 peptide-based drugs with antimicrobial or antifungal properties have received approval from the Food and Drug Administration (FDA). Peptides present a promising opportunity to address serious infections that may be challenging to manage through other means. Peptides exhibit the capability to leverage various mechanisms, and in some cases, multiple mechanisms are employed for this purpose. Despite the initial approval dating back to 1955, the FDA recently approved an echinocandin peptide just last year. The ongoing approvals underscore the significance of peptides in addressing ongoing medical challenges. Approximately 22 peptide therapeutics with an antibacterial and antifungal spectrum are currently undergoing various phases of clinical trials, showing promising results. In this review, antimicrobial and antifungal peptides are analyzed in terms of their chemical structure, indication, mode of action, and development journey, concluding with their arrival in the pharmaceutical market.

Schlagwörter

Stichwörter der Autor:innen

FDAantimicrobialbacteriaechinocandinfunguspeptidespharmaceuticals

Autor:innen und Institutionen

  • School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
  • Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK.

ORCID-Profile: Othman Al Musaimi

Zitieren

APA

Al Musaimi, O. (2025). FDA-Approved Antibacterials and Echinocandins. Antibiotics, 14(2), 166. https://doi.org/10.3390/antibiotics14020166

Vancouver

Al Musaimi O. FDA-Approved Antibacterials and Echinocandins. Antibiotics. 2025;14(2):166. doi:10.3390/antibiotics14020166

BibTeX
@article{AlMusaimi2025,
  author = {Al Musaimi, Othman},
  title = {FDA-Approved Antibacterials and Echinocandins},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {166},
  doi = {10.3390/antibiotics14020166}
}
Kostenlos starten →